E Cannabis Central: 10 Pure-Play Pot Stocks Down 45% On Average, YTD

My previous article touted the fact that, while the munKNEE.com Pure-Play Pot Stock Portfolio was down 12.8%, on average, YTD, there were 10 stocks that went up 57.2%, on average, during the same 8-month period. This is a companion article which highlights the other side of the coin - 10 stocks in the portfolio that have declined between 29% and 64% (-44.7%, on average,) YTD.

The Pure-Play Pot Stock Portfolio consists of the 25 companies that derive 100% of their revenue from the sale of cannabis or cannabis consumption products and consistently trade for at least US$1/share to reflect the true health of the marijuana industry in the U.S. and Canada. 

The 10 losers YTD are as follows, in descending order:

  1. Aurora (ACB) -64.1%
  2. Tilray (TLRY) -62.3%
  3. Harvest Health (HRVSF) -57.8%
  4. Charlotte's Web (CWBHF) -57.4%
  5. Medicine Man (SHWZ) -53.7%
  6. Avicanna (AVCNF) -51.5%
  7. Acreage (ACRGF) -51.0%
  8. Organigram (OGI) -49.8%
  9. Valens (VLNCF) -35.9%
  10. Cronos (CRON) -28.9%

Canopy, Aphria, Cresco, Greenlane and Neptune also declined 22.2%, 8.4%, 6.9%, 5.8% and 3.6% respectively.

Interestingly, four of the 10 under-performers YTD are in the Vertically Integrated (Seed-to-Sale) Category of Canadian Licensed Producers (LPs) which is down 42.9% YTD, on average, while only three are in the American Multi-State Operators (MSOs) category which is UP 21.3% YTD . 

Please leave any views or questions you have in the Comments section below. Thank you.

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.